Acute myeloid leukemia with t(10;11)(p11‐12;q23.3): Results of Russian Pediatric AML registration study. (9th January 2019)

• Record Type: Journal Article
• Authors: Zerkalenkova, Elena; Lebedeva, Svetlana; Kazakova, Anna; Tsaur, Grigory; Starichkova, Yulia; Timofeeva, Natalia; Soldatkina, Olga; Aprelova, Evgenia; Popov, Aleksandr; Ponomareva, Natalia; Baidun, Ludmila; Meyer, Claus; Novichkova, Galina; Maschan, Michael; Maschan, Aleksey; Marschalek, Rolf; Olshanskaya, Yulia
• Is Part Of: International journal of laboratory hematology. Volume 41:Number 2(2019:Apr.)
• Page Start: 287
• Page End: 292
• Publication Date: 2019-01-09
• Subjects: acute myeloblastic leukemia -- cytogenetics -- FISH -- KMT2A/MLL -- LDI‐PCR; Hematology -- Periodicals; Blood -- Diseases -- Periodicals; Hematology -- Periodicals; 616.15005
• DOI: 10.1111/ijlh.12969
• Languages: English
• ISSNs: 1751-5521

Abstract

Abstract: Introduction: Translocations involving the KMT2A gene (also known as MLL ) are frequently diagnosed in pediatric acute leukemia cases with either lymphoblastic or myeloid origin. KMT2A is translocated to multiple partner genes, including MLLT10/AF10 localizing at chromosomal band 10p12. KMT2A‐MLLT10 is one of the common chimeric genes diagnosed in acute leukemia with KMT2A rearrangement (8%), especially in acute myeloid leukemia (AML; 18%). MLLT10 is localized in very close proximity to two other KMT2A partner genes at 10p11‐12— NEBL and ABI1, so they could not be distinguished by conventional cytogenetics. Methods: In this work, we present a cohort of 28 patients enrolled into Russian Pediatric AML registration study carrying rearrangements between chromosomal regions 11q23.3 and 10p11‐12. G‐banding, FISH, reverse transcription PCR, and long‐distance inverse PCR were used to characterize the KMT2A gene rearrangements in these patients. Results: We demonstrate that 25 patients harbor the KMT2A‐MLLT10 rearrangement, while three patients show the rare KMT2A rearrangements (2× KMT2A‐NEBL ; 1× KMT2A‐ABI1 ). Conclusions: Therefore, the combination of cytogenetic and molecular genetic methods is of high importance in diagnosing cases with t(10;11)(p11‐12;q23.3).